These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27520361)

  • 1. Sequential antimicrobial treatment with linezolid for neurosurgical infections: efficacy, safety and cost study.
    Martín-Gandul C; Mayorga-Buiza MJ; Castillo-Ojeda E; Gómez-Gómez MJ; Rivero-Garvía M; Gil-Navarro MV; Márquez-Rivas FJ; Jiménez-Mejías ME
    Acta Neurochir (Wien); 2016 Oct; 158(10):1837-43. PubMed ID: 27520361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation among Chinese patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus and treated with linezolid or vancomycin: a secondary, post-hoc analysis based on a Phase 4 clinical trial study.
    Wan Y; Li Q; Chen Y; Haider S; Liu S; Gao X
    J Med Econ; 2016; 19(1):53-62. PubMed ID: 26490296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of linezolid in 16 infants and children in Japan.
    Shinjoh M; Iketani O; Watanabe K; Shimojima N; Kudo M; Yamagishi H; Shimada H; Sugita K; Takahashi T; Mori T; Hasegawa N; Iwata S
    J Infect Chemother; 2012 Aug; 18(4):591-6. PubMed ID: 22460827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linezolid-induced pancytopenia.
    Leader R; Hackett J; Allan A; Carter P
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30054325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propionibacterium acnes: an under-appreciated cause of post-neurosurgical infection.
    Nisbet M; Briggs S; Ellis-Pegler R; Thomas M; Holland D
    J Antimicrob Chemother; 2007 Nov; 60(5):1097-103. PubMed ID: 17875606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of linezolid in treatment of infection with methicillin--resistant Staphylococcus in 14 neurosurgical patients].
    Zhao ML; Sun SZ; Yang XP; Tu Y; Li JJ; Ma TZ; Zhang S
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Mar; 24(3):175-8. PubMed ID: 22401163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.
    Niederman MS; Chastre J; Solem CT; Wan Y; Gao X; Myers DE; Haider S; Li JZ; Stephens JM
    Clin Ther; 2014 Sep; 36(9):1233-1243.e1. PubMed ID: 25066668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective.
    von Dach E; Morel CM; Murthy A; Pagani L; Macedo-Vinas M; Olearo F; Harbarth S
    Clin Microbiol Infect; 2017 Sep; 23(9):659-666. PubMed ID: 28232163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative management of neurosurgical patients with methicillin-resistant Staphylococcus aureus.
    Akins PT; Belko J; Banerjee A; Guppy K; Herbert D; Slipchenko T; DeLemos C; Hawk M
    J Neurosurg; 2010 Feb; 112(2):354-61. PubMed ID: 19522572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections.
    Patanwala AE; Erstad BL; Nix DE
    Curr Med Res Opin; 2007 Jan; 23(1):185-93. PubMed ID: 17257479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus.
    Tanus T; Scangarella-Oman NE; Dalessandro M; Li G; Breton JJ; Tomayko JF
    Adv Skin Wound Care; 2014 Dec; 27(12):548-59. PubMed ID: 25396674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative use of mupirocin for the prevention of healthcare-associated Staphylococcus aureus infections: a cost-effectiveness analysis.
    Young LS; Winston LG
    Infect Control Hosp Epidemiol; 2006 Dec; 27(12):1304-12. PubMed ID: 17152027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
    Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection Rate in 1033 Elective Neurosurgical Procedures at a University Hospital in South China.
    Zhu H; Liu X; Wang Z
    J Neurol Surg A Cent Eur Neurosurg; 2017 Sep; 78(5):467-471. PubMed ID: 28437812
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with linezolid for the treatment of neurosurgical infections.
    Sousa D; Llinares P; Meijide H; Gutiérrez JM; Miguez E; Sánchez E; Castelo L; Mena A
    Rev Esp Quimioter; 2011 Mar; 24(1):42-7. PubMed ID: 21412669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients.
    Kosaka T; Kokufu T; Shime N; Sugioka N; Kato R; Hamaoka K; Fujita N
    Int J Antimicrob Agents; 2009 Apr; 33(4):368-70. PubMed ID: 19097868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL; Afghani B; Lopez P; Wu E; Fleishaker D; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.
    Itani KM; Dryden MS; Bhattacharyya H; Kunkel MJ; Baruch AM; Weigelt JA
    Am J Surg; 2010 Jun; 199(6):804-16. PubMed ID: 20227056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.